Surgical Robotics Technology
Brain Navi has announced the demonstration of NaoTrac, a neurosurgical navigation robot, and KrystoLens, a single-use neuro-endoscope, at CNS 2023 in Washington D.C. and EANS 2023 in Barcelona, respectively.
Robot-assisted surgeries minimize the risk of human error and lead to faster patient recoveries due to increased precision. NaoTrac, the surgical navigation robot, incorporates advanced software, robotics, and machine vision technologies into a single device that helps surgeons perform less invasive surgical procedures. The robot arm does non-invasive patient registration within 2 minutes, and instrument registration allows neurosurgeons to use the surgical instruments they are used to. NaoTrac is built to assist with various neurosurgical procedures including, biopsy, tumor ablation, EVD, SEEG, DBS, and cell implantation.
KrystoLens is the new single-use neuro-endoscope designed to meet unmet neuro-surgery needs. It has a wide crystal-clear working channel to ensure accuracy in surgical procedures, while the single-usage prevents post-surgery infection risk.
“NaoTrac robotic-assisted ICH treatment for patients with low mortality rate, but with severe symptoms, results in promising recovery and could be a reasonable alternative treatment choice,” said Dr. Guo Jeng-Hong, the neurosurgeon from China Medical University Hospital in Taiwan, who is to share experience during the CNS Annual Meeting.
Also shared by Dr. Stanley Chuang, the chief neurosurgeon from An-Nan Hospital attending the EANS Annual Meeting: “NaoTrac is capable of proceeding the biopsy in the prone position, saving a lot of surgical time to improve the outcome of the patient.”
“We have been constantly investing, innovating, and implementing everything possible to reflect neurosurgeons’ feedback into our products over the years. As the utilization rate of our installed base increases, we aim to introduce this new technology to more clinics and hospitals worldwide” said Dr. Jerry Chen, the CEO of Brain Navi.
Source: Brain Navi Biotechnology Co., Ltd.
